RCSB PDB - GLY Ligand Summary Page

GLY

GLYCINE

Created:1999-07-08
Last modified:  2024-09-27

Find related ligands:

Chemical Details

Formal Charge0
Atom Count10
Chiral Atom Count0
Bond Count9
Aromatic Bond Count0
2D diagram of GLY

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Chemical Component Summary

NameGLYCINE
Systematic Name (OpenEye OEToolkits)2-aminoethanoic acid
FormulaC2 H5 N O2
Molecular Weight75.067
TypePEPTIDE LINKING

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs10.04O=C(O)CN
SMILESCACTVS3.341NCC(O)=O
SMILESOpenEye OEToolkits1.5.0C(C(=O)O)N
Canonical SMILESCACTVS3.341 NCC(O)=O
Canonical SMILESOpenEye OEToolkits1.5.0 C(C(=O)O)N
InChIInChI1.03 InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
InChIKeyInChI1.03 DHMQDGOQFOQNFH-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00145 
NameGlycine
Groups
  • approved
  • vet_approved
  • nutraceutical
DescriptionA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
Synonyms
  • Glycin
  • Glycine
  • Glycocoll
  • Aminoacetic acid
  • Glicina
Brand Names
  • Aminosyn II with Electrolytes
  • Travasol Inj Without Electrolytes 5.5%
  • 8.5% Freamine III
  • Aminosyn 8.5% Injection With Electrolytes
  • Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec
IndicationSupplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
Categories
  • Amino Acids
  • Amino Acids, Peptides, and Proteins
  • Blood and Blood Forming Organs
  • Blood Substitutes and Perfusion Solutions
  • Dietary Supplements
ATC-CodeB05CX03
CAS number56-40-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Glutamate receptor ionotropic, NMDA 2AMGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERE...unknownantagonist
2-amino-3-ketobutyrate coenzyme A ligase, mitochondrialMWPGNAWRAALFWVPRGRRAQSALAQLRGILEGELEGIRGAGTWKSERVI...unknownsubstrate
5-aminolevulinate synthase, non-specific, mitochondrialMESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALST...unknownsubstrate
5-aminolevulinate synthase, erythroid-specific, mitochondrialMVTAAMLLQCCPVLARGPTSLLGKVVKTHQFLFGIGRCPILATQGPNCSQ...unknownsubstrate
Glycine--tRNA ligaseMPSPRPVLLRGARAALLLLLPPRLLARPSLLLRRSLSAASCPPISLPAAA...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL773
PubChem 5257127, 750
ChEMBL CHEMBL773
ChEBI CHEBI:57305, CHEBI:15428
CCDC/CSD DGLYCN01